Comparison of extended release GLP-1 receptor agonist therapy versus sitagliptin in the management of type 2 diabetes

por Stolar, Mark W, Grimm, Michael, Chen, Steve
Publicado 2013

COVID-19-Induced Diabetic Ketoacidosis in an Adult with Latent Autoimmune Diabetes

por Omotosho, Yetunde B, Ying, Grace W, Stolar, Mark, Mallari, Arvin Junn P
Publicado 2021

Managing Type 2 Diabetes: Going Beyond Glycemic Control

por Stolar, Mark W., Hoogwerf, Byron J., Boyle, Patrick J., Gorshow, Stephen M., Wales, Dirk O.
Publicado 2008